← Back to All Filings

IQVIA CEO Exercises Options, Sells $17.1M in Stock (IQV)

Medium SignificanceOctober 31, 2025 at 5:02:51 PM EDT

IQVIA HOLDINGS INC.

$IQV4CIK: 0001478242

Subscribe to track IQV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

IQVIA CEO Exercises Options, Sells $17.1M in Stock (IQV)

Company: IQVIA HOLDINGS INC. (IQV) Form: 4 | Filed: 2025-10-31 Significance: Medium

Insider: BOUSBIB ARI Title: Chairman, Chief Executive Officer & President | Relationship: Director, Officer

Transaction: • Type: Exercise & Sell • Shares Sold: 77,592 • Avg. Price: $220.51 • Value: $17,109,928 • Owned After: 1,350,465 (Direct & Indirect)

Key Insight: The CEO exercised 77,592 Stock Appreciation Rights and sold the same number of shares in a 'cashless exercise', a common way to realize value from equity awards and cover costs/taxes. The transaction represents a significant $17.1M liquidity event for the executive but does not reduce his pre-existing share ownership.

Market Context: For a large-cap company like IQVIA ($36.86B), this transaction represents a small fraction (<0.05%) of market cap and shares outstanding, making it a routine executive compensation event rather than a bearish signal.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: IQVIA HOLDINGS INC. (IQV)

Executive Summary

  • Trading Significance: Medium
  • Key Takeaway: The Chairman & CEO, Ari Bousbib, conducted a 'cashless exercise' of stock appreciation rights, resulting in the sale of 77,592 shares for a total value of approximately $17.1 million. This is a planned liquidity event, not a discretionary sale of existing holdings.
  • Market Impact: The impact is likely neutral. While a large absolute value, the transaction is a routine executive compensation event and represents a very small percentage of the company's market capitalization.

Company Information

FieldValue
CompanyIQVIA HOLDINGS INC.
Ticker SymbolIQV
CIK0001478242
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Insider Information

FieldValue
NameBOUSBIB ARI
CIK0001184180
Title/PositionChairman, Chief Executive Officer & President
RelationshipDirector, Officer

Transaction Details

This filing reports the exercise of derivative securities and subsequent sale of common stock.

Aggregate Sale Transaction:

FieldValue
Form Type4
Transaction Date2025-10-29
Transaction CodeS, M, D (Sale, Exercise, Disposition)
Security TypeCommon Stock
Shares Involved77,592 (Sold)
Price Per Share$220.51 (Weighted Average)
Total Value$17,109,928
Shares Owned After1,350,465 (807,163 Direct, 543,302 Indirect)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$17,109,928
% of Market Cap0.046%
Shares Transacted77,592
% of Shares Outstanding0.046%
Post-Transaction Ownership1,350,465 shares (0.79% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of $36.86 billion, a $17.1 million transaction is not financially material to the company's overall valuation, representing less than 0.05% of its market cap.
  • Ownership Concentration: The CEO's post-transaction ownership of 1.35 million shares, or 0.79% of the company, remains a substantial holding, aligning his interests with shareholders.
  • Dilution Impact: The transaction originates from the exercise of previously granted Stock Appreciation Rights (SARs). The dilutive effect occurred when these awards were initially granted and accounted for. This exercise simply converts that potential dilution into actual shares, which were then immediately sold.
  • Transaction Significance: The significance is rated 'Medium' not due to its market impact, but because it involves the CEO and a large absolute dollar amount. It provides insight into executive compensation realization but is not indicative of a change in the insider's outlook on the company, as it's a non-discretionary sale to cover the cost of exercising derivatives.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The market typically understands that 'exercise and sell' transactions are pre-planned and necessary for executives to pay exercise prices and taxes. Since the number of shares sold equals the number of SARs exercised, it does not signal a change in the CEO's long-term conviction.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The trades are often handled by brokers in a way that minimizes market disruption.
  • Sentiment Indicator: Neutral. This is viewed as a routine part of an executive compensation package rather than a bearish signal.

Investment Insights

Positive Market Indicators

  • The CEO maintains a significant ownership stake of over 1.3 million shares post-transaction, valued at over $290 million at current prices.

Risk Factors

  • No new risk factors are indicated by this filing. It is a standard executive transaction.

Key Takeaways

  1. CEO Cashes Out on Awards: Ari Bousbib realized $17.1 million in value from vested stock appreciation rights.
  2. Not a Discretionary Sale: This was a 'cashless exercise' where the shares sold were used to fund the exercise and associated taxes. The CEO did not sell from his existing personal holdings.
  3. Low Relative Impact: Despite the large dollar value, the transaction is very small relative to IQVIA's $36.86B market cap and 170M shares outstanding, making it immaterial from a market perspective.

Additional Context

Transaction Notes

  • Footnotes: The filing's footnotes confirm the sales were executed at weighted average prices and were related to the exercise of stock appreciation rights expiring in February 2026. One disposition of 21,035 shares (coded 'D') was likely to cover tax withholding obligations.
  • Special Circumstances: This is a classic example of a non-open market disposition tied to an equity award plan.
Topics:#SECFiling#InsiderTrading#IQV#IQVIA#Form4#InsiderSell#StockMarket#Investing#CEO#HealthcareTech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.